VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > News

<< Previous

Bullboard Posts

Next >>

Post by banderas1976on Feb 14, 2022 8:41am

432 Views

Post# 34425638

News

Attached is a special publication which appeared in the Toronto Star and distributed nationally this weekend as part of Heart Month - February series.

A focus this week was Congenital Heart Disease and Ventripoint received an endorsement from Allan Weatherall, Executive Director, Canadian Congenital Heart Alliance (CCHA).

The digital campaign landing page is here, and the digital article is here.

With our new Investor relations group, Iconic, we will be holding an investor update this week (see detail below). Please join if you can.

Regards,

Dr. George Adams ICD.D

Executive-Chairman

Ventripoint Diagnostics Ltd.

TSXV-VPT

www.ventripoint.com

519-803-6937

------------------------------------------------------------------

<< Previous

Bullboard Posts